Menu

Mark Ballantyne

Associate

I love the challenges of working with technology and life sciences companies as they evolve from startups to public companies.

+1 703 456 8084
mballantyne@cooley.com

Mark Ballantyne focuses his practice on representing IPO ready and publicly traded life sciences and technology companies, as well as underwriters.

Download full bio

Experience

  • Legend Biotech - $487 Million IPO 

  • LogicBio Therapeutics – $80.5 Million IPO 

  • Verrica Pharmaceuticals – $86 Million IPO 

  • Translate Bio – $122 Million IPO 

  • Aclaris Therapeutics IPO 

  • View all

Practices & Industries
Passions

    Golfing

    Traveling

Education

  • University of Richmond School of Law
    JD, magna cum laude, Order of the Coif, McNeill Law Society, 2012

  • Wake Forest University
    BA, 2008

Admissions & Credentials

Virginia

Media & Insight
Rankings & Accolades

    Best Lawyers: Ones to Watch - Securities/Capital Markets Law and Venture Capital Law (2021)

Contact

+1 703 456 8084 office
+1 703 456 8100 fax
mballantyne@cooley.com

Reston Town Center
11951 Freedom Drive
14th Floor
Reston, VA 20190-5640

Back to top

© 2020 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.